Abstract
According to WHO, PTSD is one of the diagnoses causing the highest number of “days out of role”/year. Current recommendations for evidence-based treatment of PTSD are largely the same across international guidelines. Common to these is that psychotherapeutic treatment is first-choice and psychopharmacological treatment issecond choice. First-choice psychotherapeutic treatment is trauma-focused cognitive behavioural therapy, whileSSRIs are first-choice psychopharmacological treatment. However, there is still a need for further research intotreatments as well as optimising access to existing treatment options.
Bidragets oversatte titel | Psychotherapeutic and psychopharmacological treatment of PTSD |
---|---|
Originalsprog | Dansk |
Artikelnummer | V11210872 |
Tidsskrift | Ugeskrift for Læger |
Vol/bind | 184 |
Antal sider | 7 |
ISSN | 0041-5782 |
Status | Udgivet - 2022 |